Dietary DHA has the capacity to suppress markers of hepatic damage, hepatic inflammation, oxidative stress and fibrosis in LDLR-/- mouse with induced non-alcoholic steatohepatitis [55] and is reported to be beneficial in hepatic encephalopathy [56]. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.